MET and neoplasm: Deletion of FAK in hepatocytes blocks tumor proliferation and prolongs the survival in a c-Met/β-catenin-driven hepatocellular carcinoma (HCC) mouse model [104], suggesting that FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis.